The Changing Lexicon of Wound Treatment

Abstract

Get full access to this article

View all access options for this article.

References

1. Gilje O. On taping (adhesive tape treatment) of leg ulcers. Acta Dermatol Venereol 1948;28:454-467.

2. Winter GD. Formation of the scab and the rate of epithelisation of superficial wounds in the skin of the young domestic pig. Nature (London) 1962;193:293-294.

3. Winter GD. Epidermal regeneration in the domestic pig. In Maibach HI, Rovee DT, editors. Epidermal wound healing. Chicago: Yearbook Medical; 1972:71-112.

4. Hinman CD, Maibach HI. Effect of air exposure and occlusion on experimentalhumanskin wounds. Nature (London) 1963;200:377-379.

5. Rovee DT, Kurowsky CA, Labun J, Downes AM. Effect of local wound environment on epidermal healing. In Maibach HI, Rovee DT, editors. Epidermal wound healing. Chicago: Yearbook Medical; 1972:159-181.

6. Cohen S. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the newborn animal. J Biol Chem 1962;237:1555-1562.

7. Cohen S, Taylor JM. Epidermal growth factor: chemical and biological characterization. In Maibach HI, Rovee DT, editors. Epidermal wound healing. Chicago: Yearbook Medical; 1972:203-218.

8. Steed DL. Clinical evaluation of recombinant human plateletderived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group. J Vasc Surg 1995;21:71-78.

9. Wieman TJ, Smiell JM, Su Y. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. Diabetes Care 1998;21:822-827.

10.

10. Tomic-Canic M, Agren MS, Alvarez OM. Epidermal repair and the chronic wound. In Rovee DT, Maibach HI, editors. The epidermis in wound healing. Boca Raton, FL: CRC Press; 2003:25-57.

11.

11. Hebda PA, Sandulache VC. The biochemistry of epidermal healing. In Rovee DT, Maibach HI, editors. The epidermis in wound healing. Boca Raton, FL: CRC Press; 2003:60-86.

12.

12. Rheinwald JG, Green H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 1975;6:331-343.

13.

13. Yannas IV, Burke JF, Gordon P, Huang C, Rubenstein RH. Design of an artificial skin: II. Control of chemical composition. JBiomed Mater Res 1980;14:107-132.

14.

14. Falanga V, Margolis D, Alvarez O, et al. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators Group. Arch Dermatol 1998;134:293-300.

15.

15. Veves A, Falanga V, Armstrong DG, Sabolinski ML. The Apligraf Diabetic Foot Ulcer Study. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care 2001;24:290-295.

16.

16. Gentzkow GD, Iwasaki SD, Hershon KS, et al. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care 1996;19:350-354.

17.

17. Enoch S, Harding K. Wound bed preparation: the science behind the removal of barriers to healing. Wounds 2003;15:213-229.

18.

18. Sibbald RG, Williamson D, Orsted HL, et al. Preparing thewound bed—debridement, bacterial balance, and moisture balance. Ost Wound Manag 2000;46:14-35.

19.

19. Falanga V. Wound bed preparation and the role of enzymes: a case for multiple actions of therapeutic agents. Wounds 2002;14:47-57.

20.

20. Donohue K, Rausch H, Falanga V. Wound bed preparation. In Rovee DT, Maibach HI, editors. The epidermis in wound healing. Boca Raton, FL: CRC Press; 2003:255-264.